DOI: 10.4244/EIJV9I5A105

A plea for caution: transcatheter aortic valve implantation using the Medtronic CoreValve™ prosthesis without balloon predilatation

Ralf Zahn1*, MD; Timm Bauer1, MD; Falk-Udo Sack1, MD; Andreas Lehman2, MD; Bernd Cornelius3, MD; Rudolf Schiele1, MD

An 87-year-old woman with severe symptomatic aortic stenosis was selected for TAVI by the Heart Team because of a high surgical risk (log. EuroSCORE: 24.2%). The mean transvalvular gradient was 56 mmHg and the diameter of the aortic annulus 21 mm. Therefore a 26 mm CoreValve™ prosthesis (Medtronic, Minneapolis, MN, USA) was selected. We decided to perform the procedure without prior balloon valvuloplasty. After femoral access with an 18 Fr sheath, a stiff guidewire was placed in the left ventricle. The prosthesis was advanced over the stenotic valve without problems (Figure 1A). The sheath cover was then retracted under fluoroscopic guidance and the valve released. It became apparent that the valve was highly compressed in its distal part and the position seemed optimal, with the distal end of the prosthesis reaching one cell (8 mm) into the left ventricular outflow tract (Figure 1B). We decided to perform a balloon dilatation with a 22 mm Nucleus™ balloon (NuMED, Hopkinton, NY, USA). In the meantime, before the balloon was advanced over the valve, we saw that the valve had moved upwards, reaching now only half a cell below the annulus (Figure 1C). We rapidly performed the balloon valvuloplasty (Online Figure 1) which led to an appropriate expansion of the distal part of the valve, with the distal part of the prosthesis now ending only one to two millimetres below the annulus (Online Figure 2). Angiography showed that there was no residual aortic insufficiency (Online Figure 3).

Figure 1. A) Positioning of the Medtronic CoreValve™ prosthesis. B) Result after release of the prosthesis: good placement but compression of the distal part of the prosthesis. C) Result after positioning of a balloon: spontaneous cranial dislodgement of the prosthesis.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Online Figure 1. Balloon valvuloplasty with a 22 mm Nucleus™ balloon.

Online Figure 2. Result after balloon valvuloplasty.

Online Figure 3. Final angiography, demonstrating no residual insufficiency.

Volume 9 Number 5
Sep 27, 2013
Volume 9 Number 5
View full issue


Key metrics

On the same subject

Image – Interventional flashlight

10.4244/EIJ-D-19-00690 Aug 28, 2020
Transcatheter aortic valve implantation after transcatheter mitral valve implantation
Kuhn E et al
free

10.4244/EIJV7I1A25 May 17, 2011
How should I treat acute valve regurgitation?
Schultz C et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJ-D-16-00064 Dec 9, 2016
Complete blood flow obstruction due to a distally embolised Edwards SAPIEN valve prosthesis
Nijenhuis VJ et al
free

CLINICAL RESEARCH

10.4244/EIJ-D-17-00252 Dec 20, 2017
Very low pacemaker rate following ACURATE neo transcatheter heart valve implantation
Toggweiler S et al
free

10.4244/EIJV9I5A104 Sep 27, 2013
How should I treat severe paravalvular leakage after TAVI?
Reinthaler M et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJY15M06_01 Mar 18, 2016
How to overcome a scary complication: a mesh-trapped balloon during a CoreValve® implantation procedure
Bayet G et al
free
Trending articles
203.9

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
75.15

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
69.7

Clinical research

10.4244/EIJ-D-20-00763 Dec 18, 2020
Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system
Verheye S et al
free
58.35

Clinical research

10.4244/EIJ-D-20-00975 May 16, 2021
Revascularisation or medical therapy in elderly patients with acute anginal syndromes: the RINCAL randomised trial
de Belder A et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved